Recently, phenotypical and functional analysis unraveled that the expansion of DN B cells in SLE patients is attributable to a sub-phenotype denominated DN2, which lacks the homing receptor CXCR5 and the complement receptor CD21, but expresses the integrin subunit CD11c (8). This evidence concerns the gene CR2 and systemic lupus erythematosus.